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exploring Collagen parameters 
in pure special types of Invasive 
Breast Cancer
Rodrigo de Andrade Natal  1, Geisilene R. paiva2, Vitor B. pelegati3, Ludwing Marenco  3,  
César A. Alvarenga4, Renato F. Vargas2, sophie F. Derchain5, Luis o. sarian5, 
Camille Franchet6, Carlos L. Cesar3,7, Fernando C. schmitt8,9, Britta Weigelt10 & José Vassallo1
one of the promising tools to evaluate collagen in the extracellular matrix is the second-harmonic 
generation microscopy (sHG). this approach may shed light on the biological behavior of cancers 
and their taxonomy, but has not yet been applied to characterize collagen fibers in cases diagnosed 
as invasive breast carcinoma (BC) of histological special types (IBC-ST). Tissue sections from 99 
patients with IBC-ST and 21 of invasive breast carcinoma of no special type (IBC-NST) were submitted 
to evaluation of collagen parameters by sHG. tissue microarray was performed to evaluate 
immunohistochemical-based molecular subtype. In intratumoral areas, fsHG and bsHG (forward-
sHG and backward-sHG) collagen parameters achieved their lowest values in mucinous, papillary and 
medullary carcinomas, whereas the highest values were found in classic invasive lobular and tubular 
carcinomas. Unsupervised hierarchical cluster analysis and minimal spanning tree using intratumoral 
collagen parameters allowed the identification of three main groups of breast cancer: group A (classic 
invasive lobular and tubular carcinomas); group B (IBC-Nst, metaplastic, invasive apocrine and 
micropapillary carcinomas); and group C (medullary, mucinous and papillary carcinomas). Our findings 
provide further characterization of the tumor microenvironment of IBC-st. this understanding may add 
information to build more consistent tumor categorization and to refine prognostication.
Invasive breast carcinoma is considered a combination of heterogeneous diseases, encompassing multiple entities 
with distinct biological and clinical features. The most common subtype of breast carcinoma is invasive ductal 
carcinoma of no special type (IBC-NST), formerly known as invasive ductal carcinoma, which accounts for 
around 50% to 80% of all breast cancers1–3. The remaining tumor subtypes are collectively referred to as inva-
sive carcinoma with histological special types (IBC-ST), and account for approximately 25% of invasive breast 
carcinomas1–4. Although pathologists have been aware of the diversity of breast cancers and have endeavored to 
devise approaches to classify the disease into meaningful groups3,5–9, this concept has only been brought to the 
forefront of breast cancer research after the publication of high-throughput microarray-based discovery studies 
that unraveled the existence of multiple molecular subtypes10–13.
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IBC-ST refers to the architectural growth of the tumors, defining special morphological and cytological pat-
terns, which have been consistently associated with distinctive clinical presentation and/or outcomes3. However, 
although histological grade identifies prognostic subgroups in IBC-NST, among the IBC-ST some subtypes show 
high grade but still bear favorable prognosis (e.g. medullary, mucinous and invasive apocrine breast carcinomas)3. 
Interestingly, genetic and transcriptomic features of breast cancers has been correlated with histological grade, 
and microarray-based genomic signatures for histological grades have been devised14–17.
The use of new investigation tools in IBC-ST has been limited partly due to their relative low prevalence with 
consequent lower interobserver reproducibility, skewing their systematic investigation in class discovery10–13 and 
class prediction16,18–21. This is the case of tumor microenvironment, especially the extracellular matrix (ECM), 
which has been intensively studied in tumor progression and outcome22. Among the various components of 
ECM, collagen fibers are the most abundant in breast cancer stroma23,24. The restructuring of collagen pattern 
may be either induced by tumor cells, or occur as a result of an integrated modification between neoplastic cell 
and stroma, suggesting that progression of a tumor relies not only on changes of cell function, but also on ECM 
alterations.
One of the promising tools to evaluate collagen in the ECM during cancer progression is the second-harmonic 
generation microscopy (SHG)25–27. This approach may shed light on the biological behavior of cancers and their 
taxonomy28,29. It allows for the identification of collagen maturation process by distinguishing collagen diameters. 
Thus, backward SHG images exhibit punctate distribution attributable to small-diameter, segmental collagen, 
which permits recognition of fibrillogenesis in immature tissue by directly imaging backward-propagating SHG 
(bSHG). By contrast, images from the mature fibrils are identical in the forward (fSHG) and backward direc-
tions30. Although it has not been applied to IBC-ST, several studies have shown that this is an efficient means to 
describe common breast diseases, differentiate benign from malignant breast tissue and establish prognosis in 
invasive ductal carcinoma31–35. It should be emphasized that studies also indicate that certain aspects of collagen 
deposition may lead to a more aggressive behavior of the tumor, like greater amount of collagen, presence of 
perpendicular fibers to the tumor bounder and thicker collagen fibers34,36–38. Thus, the goals of the present study 
are: (1) to investigate peri- and intratumoral collagen parameters in various histological subtypes of pure IBC-ST, 
using IBC-NST as standard samples, and (2) correlate these parameters with pathological and clinical features.
Results
Clinicopathological features. Patients’ age, histological grade, lymph node status and immunohisto-
chemical-based molecular subtype39 are shown in Table 1. The median age was 56 years [Interquartile range 
(IQR) = 45–66 years]. Among all 120 cases, most carcinomas were of histological grade III (n = 48; 40.0%), fol-
lowed by grade I (n = 43; 35.8%) and grade II (n = 29; 24.2%) carcinomas. The majority of the patients did not 
present lymph node metastases (n = 54; 45.0%); these were found in 25 patients (20.8%). According to the status 
of immunohistochemical expression of hormone receptors (HR) and HER2/neu protein used as surrogate for 
molecular types, cases were classified as follows: HR+HER2− was the most frequent subtype (n = 55; 45.8%), fol-
lowed by HR−HER2− (n = 26; 21.7%), HR+HER2+ (n = 4; 3.3%), and HR−HER2 + (n = 4; 3.3%). In 31 cases 
(25.8%), patients had no further material for immunohistochemical staining, thus immunohistochemical-based 
molecular subtyping was not possible for these patients.
Histological types n (%)
Median 
(IQR#), 
years
Histological 
grade Lymph node status Molecular subtype
I II III Negative Positive
Not 
available
HR+ 
HER2−
HR+ 
HER2+
HR− 
HER2+
HR− 
HER2−
Not 
available
Classic invasive lobular 7 (07.1%) 57 (57–59) 3 2 2 2 1 4 5 — — 1 1
Tubular 13 (13.1%) 50 (45–64) 13 — — 9 2 2 8 — — — 5
Mucinous 23 (23.2%) 65 (47–74) 17 5 1 11 4 8 15 — — — 8
   Mucinous A 13 (13.1%) 66 (54–76) 12 1 — 6 3 4 8 — — — 5
   Mucinous B 10 (10.1%) 63 (42–70) 5 4 1 5 1 4 7 — — — 3
Papillary 9 (09.1%) 61 (52–79) 1 5 3 6 1 2 8 — — — 1
Micropapillary 6 (06.1%) 48 (42–63) — 2 4 1 4 1 4 1 — — 1
Medullary 15 (15.2%) 47 (38–54) — 2 13 9 4 2 1 — — 10 4
   Typical 6 (06.1%) 48 (36–58) — — 6 4 2 — — — — 6 —
   Atypical 9 (09.1%) 47 (45–51) — 2 7 5 2 2 1 — — 4 4
Metaplastic 9 (09.1%) 51 (33–56) — 4 5 2 — 7 — — — 8 1
   Matrix-producing 4 (04.0%) 56 (50–59) — 2 2 1 — 3 — — — 4 —
   Squamous cell 4 (04.0%) 40 (35–46) — 1 3 1 — 3 — — — 3 1
   Spindle cell 1 (01.0%) 8 (NA) — 1 — — — 1 — — — 1 —
Apocrine 17 (17.1%) 61 (46–69) — 3 14 8 6 3 4 3 4 3 3
Total (IBC-ST) 99 (100.0%) 56 (45–66) 43 29 48 54 25 41 45 04 04 22 24
IBC-NST 21 58 (50–61) 9 6 6 6 3 12 10 — — 4 7
Table 1. Clinicopathological features of breast carcinoma cases. #IQR = interquartile range.
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Collagen features in breast cancer. The correlation between collagen parameters (quantity, uniformity 
and organization) in peritumoral areas was poor, contrasting to high correlation coefficients found in intratu-
moral areas (Supplementary Table 1 and Fig. 1).
In general, collagen quantity, uniformity and organization were higher in peritumoral regions compared to 
intratumoral areas (Supplementary Table 2). In classic invasive lobular, tubular, micropapillary and metaplastic 
carcinomas, there was no statistical difference between fSHG peri- and intratumoral collagen organization. The 
same was observed for bSHG peri- and intratumoral collagen organization in classic invasive lobular and micro-
papillary carcinomas.
Peritumoral collagen parameters for both fSHG and bSHG fibers did not differ significantly across histological 
subtypes (Table 2 and Supplementary Fig. 2). In contrast, in intratumoral areas, fSHG and bSHG collagen quan-
tity, uniformity and organization achieved the lowest values in mucinous, papillary and medullary carcinomas, 
whereas the highest values for these parameters were found in classic invasive lobular and tubular carcinomas 
(Table 2, Fig. 1, Supplementary Table 3).
Peritumoral and intratumoral bSHG collagen quantity (p = 0.008 and p = 0.003, respectively) and uniformity 
(p = 0.009 and p = 0.005, respectively) were higher in histological grade I tumors compared to grade III tumors. 
However, there was no difference between peri- and intratumoral collagen quantity and uniformity, considering 
histological grade II tumors and grade I or histological grade II and grade III tumors. Peri- and intratumoral col-
lagen organization was similar across histological grades (Supplementary Table 4). Peritumoral collagen quantity, 
uniformity and organization did not differ in relation to lymph node status and immunohistochemical-based 
subtype. However, intratumoral collagen bSHG fiber uniformity and organization were higher in HR−HER2− 
tumors compared to HR−HER2+ tumors (Supplementary Table 5).
The multivariate recursive partitioning method, using intratumoral collagen parameters, showed that fSHG 
and bSHG quantity, uniformity and organization were lower in mucinous, papillary and medullary tumors 
(p < 0.001). On the other hand, the three parameters were significantly higher in classic invasive lobular and 
tubular carcinomas (p = 0.005) compared to the other histological subtype. IBC-NST, micropapillary, metaplastic 
and invasive apocrine carcinomas presented an intermediary fSHG and bSHG intratumoral collagen parameters 
(Supplementary Fig. 3).
Unsupervised hierarchical cluster analysis using intratumoral collagen (Fig. 2 and Supplementary Figs 4 and 5) 
allowed the identification of three main groups of breast cancer. Group A: high intratumoral collagen quantity, 
uniformity and organization (classic invasive lobular and tubular carcinomas); group B: intermediary intratu-
moral collagen quantity, uniformity and organization (invasive ductal, metaplastic, invasive apocrine and micro-
papillary carcinomas); and group C: low intratumoral collagen quantity, uniformity and organization (medullary, 
mucinous and papillary carcinomas). Supervised analysis using estrogen receptor (ER) expression or molecular 
subtype presented the same result. Figure 3 visually summarizes the distinct groups of breast carcinomas accord-
ing to intratumoral collagen parameters.
Collagen 
parameters IBC-NST
Classic invasive 
lobular Tubular Mucinous Papillary Micropapillary Medullary Metaplasic Apocrine
Peritumoral
bSHG collagen 
quantity† 13.61 (0.42) 13.84 (0.46) 13.86 (0.34) 13.58 (0.42) 13.39 (0.31) 13.74 (0.52) 13.34 (0.51) 13.20 (0.47) 13.48 (0.35)
fSHG collagen 
quantity† 14.03 (0.48) 14.19 (0.52) 14.05 (0.35) 13.85 (0.43) 13.75 (0.56) 14.13 (0.52) 13.79 (0.65) 13.75 (0.43) 13.87 (0.30)
bSHG collagen 
uniformity† 5.08 (0.50) 5.40 (0.56) 5.36 (0.39) 5.11 (0.51) 4.81 (0.38) 5.24 (0.56) 4.82 (0.58) 4.64 (0.52) 4.89 (0.42)
fSHG collagen 
uniformity† 5.84 (0.70) 6.07 (0.69) 5.82 (0.47) 5.67 (0.58) 5.37 (0.92) 5.94 (0.58) 5.67 (0.81) 5.59 (0.48) 5.63 (0.49)
bSHG collagen 
organization† 0.16 (0.04) 0.19 (0.04) 0.17 (0.05) 0.15 (0.04) 0.16 (0.05) 0.17 (0.06) 0.16 (0.04) 0.15 (0.03) 0.15 (0.03)
fSHG collagen 
organization† 0.44 (0.07) 0.49 (0.08) 0.48 (0.08) 0.44 (0.08) 0.44 (0.08) 0.49 (0.17) 0.45 (0.05) 0.42 (0.05) 0.45 (0.09)
Intratumoral
bSHG collagen 
quantity† 11.68 (0.73) 12.21 (0.80) 12.31 (0.66) 10.80 (0.76) 10.64 (0.17) 10.64 (0.50) 10.73 (0.41) 11.26 (0.43) 11.30 (0.74)
fSHG collagen 
quantity† 11.56 (1.04) 12.00 (0.74) 12.13 (0.82) 9.83 (1.68) 9.21 (0.95) 11.40 (0.76) 9.83 (1.14) 11.21 (0.62) 11.02 (1.02)
bSHG collagen 
uniformity† 2.86 (0.86) 3.61 (1.02) 3.50 (0.90) 1.93 (1.01) 1.45 (0.25) 3.21 (0.61) 1.67 (0.53) 2.28 (0.53) 2.44 (0.94)
fSHG collagen 
uniformity† 2.86 (1.31) 3.44 (0.74) 3.25 (1.18) 0.99 (2.37) −0.42 (1.54) 3.04 (1.05) 0.83 (1.73) 2.44 (1.02) 2.35 (1.60)
bSHG collagen 
organization† 0.08 (0.04) 0.14 (0.06) 0.11 (0.04) 0.04 (0.04) 0.01 (0.02) 0.10 (0.04) 0.04 (0.03) 0.05 (0.04) 0.07 (0.04)
fSHG collagen 
organization† 0.37 (0.12) 0.46 (0.08) 0.41 (0.10) 0.18 (0.16) 0.08 (0.12) 0.44 (0.11) 0.21 (0.14) 0.33 (0.13) 0.34 (0.13)
Table 2. Collagen parameters in invasive breast carcinoma. †Data in: Mean (Standard deviation).
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Mucinous, medullary and metaplastic breast carcinoma subclassification. Collagen parameters 
did not differ between mucinous A and B breast carcinoma. In addition, peritumoral collagen parameters in 
typical and atypical medullary were similar. Intratumoral fSHG collagen quantity (p = 0.017) and uniformity 
(p = 0.044) were higher in atypical medullary breast cancer; these findings may be extended to bSHG fiber quan-
tity (p = 0.054) and uniformity (p = 0.054); fSHG and bSHG fiber organization was similar in both tumor sub-
types (p = 0.198 and p = 0.064, respectively).
There were no differences in collagen parameters comparing metaplastic breast carcinoma with squamous 
cells and with matrix-producing breast carcinomas, except for peritumoral fSHG collagen organization, that was 
higher in metaplastic breast carcinoma with squamous cells (p = 0.017).
Discussion
Our results allowed grouping breast carcinomas according to the intratumoral collagen parameters (Fig. 3). Group 
A, characterized by higher intratumoral collagen quantity, uniformity and organization, was enriched for classic 
invasive lobular and tubular carcinomas; group B, comprised by intermediary intratumoral collagen quantity, uni-
formity and organization, was enriched for IBC-NST, metaplastic, invasive apocrine and micropapillary carcino-
mas; and group C, covered lower intratumoral collagen quantity, uniformity and organization, was enriched for 
Figure 1. Boxplots demonstrating the distribution of intratumoral collagen parameters in histological subtypes: 
(A) bSHG collagen quantity; (B) fSHG collagen quantity; (C) bSHG collagen uniformity; (D) fSHG collagen 
uniformity; (E) bSHG collagen organization; (F) fSHG collagen organization. Classic invasive lobular (2. cILC) 
and tubular (3. TUB) carcinomas presented the highest values for intratumoral collagen parameters. Mucinous 
(4. MUC), papillary (5. PAP) and medullary (7. MED) presented the lowest values. Invasive ductal carcinoma 
of no special type (1. IBC-NST), micropapillary (6. mPAP), metaplastic (8. METAP) and invasive apocrine (9. 
APO) presented intermediary values of intratumoral collagen parameters. The statistically significant relations 
are shown in Supplementary Table 3. [bSHG, fSHG: backward and forward propagation second harmonic 
generation, respectively].
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medullary, mucinous and papillary carcinomas. Furthermore, it would be worth highlighting that IBC-NST are not 
only heterogeneous at the morphologic and molecular level, but also at the clustering analysis performed herein; 
cases of IBC-NST could be found in any of the possible three groups identified, even if we used a supervised clus-
tering analysis.
Figure 2. (A) Unsupervised hierarchical clustering of intratumoral collagen parameters using Ward algorithms and 
Euclidian distance; the lowest values for intratumoral collagen parameters refer to mucinous (MUC), papillary (PAP) 
and medullary (MED) breast carcinomas (light blue); the highest values refer to classical invasive lobular (cILC) and 
tubular carcinomas (TUB) (light yellow); the intermediary values refer to invasive ductal carcinoma of no special type 
(IBC-NST), micropapillary (mPAP), metaplastic (METAP) and invasive apocrine (APO) (light orange), being the 
latter group very heterogeneous. QIR: bSHG collagen quantity; QIT: fSHG collagen quantity; EIR: bSHG collagen 
uniformity; EIT: fSHG collagen uniformity; OIR: bSHG collagen organization; and OIT: fSHG collagen organization. 
(B) Minimal Spanning Tree (MST) of the Euclidian matrix with three defined intratumoral collagen parameters. The 
MSP gives a spatial representation of what is shown in the heatplot. Cases presenting similar collagen parameters 
are linked by a line. As result, cases belonging to the same group (blue, yellow and orange) are concentrated in three 
branches of the tree: blue in the superior part, yellow in the middle and right region and orange in the left branch.
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The findings on intratumoral collagen corroborate the disparities between morphological classification and 
molecular biology. Heterogeneous tumor biology may be found within the same histological subtype, whereas 
distinct histological categories share common molecular features39,40. As such, morphologic subtyping may be 
challenging not only because of subjectivity, but also as a result of molecular similarities. Peritumoral collagen 
fibers presented similar parameters among all histological subtypes of breast cancer, suggesting a common end-
point, shared by them, in the mechanism of collagen deposition at tumor periphery. This acknowledgement may 
support the pivotal interplay of tumor microenvironment in cancer outcome.
Classic invasive lobular and tubular carcinomas, constituting group A in the present study, have been 
described as showing remarkably similar immunohistochemical and transcriptomic profiles39. Notwithstanding, 
invasive lobular carcinoma can be differentiated from tubular carcinoma based on the expression levels of 
E-cadherin, which is absent in the former41,42. Regarding collagen parameters, both histological subtypes pre-
sented similar intratumoral features, and shared the same hierarchical clustering, supporting the acquaintance 
between them. These findings provide structural evidence for the hypothesis that classic invasive lobular and 
tubular carcinomas, both frequently members of the low-grade breast carcinoma group, might originate from the 
same family of low-grade precursors41. Lopez-Garcia et al. support the existence of a “low-grade breast neoplasia 
family”; nevertheless, the transcriptomes of these lesions display small, yet important differences, which together 
with their distinct biological behavior, warrant their separation as discrete entities43.
In opposition to the subtypes above, a clear disparity in the clinical, morphological, molecular or immunohis-
tochemical profiles was found within the other two groups of tumors with similar intratumoral collagen param-
eters, groups B and C39,40,44. This is evidence that, although the microenvironment may importantly contribute 
to progression of cancer in all phases, factors intrinsic to the neoplastic cells may respond for other important 
features, as the phenotype and genetic characteristics39,40.
Subtypes included in our group B have been described as presenting discrepant clinicopathological behavior. 
Metaplastic and micropapillary carcinomas present mostly poor outcome, in spite of ER status, respectively, neg-
ative and positive; apocrine carcinoma, tipically ER-negative, present variable outcome45,46. In a study of genomic 
profiling, carcinomas with apocrine differentiation, invasive micropapillary and metaplastic carcinomas showed 
the highest frequencies of chromosome aberrations (i.e. gene amplifications, gains and losses)40. Thus, although 
this group seems heterogeneous as for clinical outcome and for the variable expression of ER, the collagen param-
eters behaved similarly, and paralleled the high numbers of chromosome aberrations. It may be assumed that the 
collagen signature of group B is predictive of higher frequency of finding genetic alterations.
On the other hand, group C, enriched for medullary, mucinous and papillary carcinomas have been related 
to a more indolent clinical behavior45. The three subtypes in group C have been described with similar gross 
growth pattern in image exams, presenting as a round or oval tumor with well-defined contours47. Genetic results 
demonstrated that papillary carcinomas are a homogenous special histological subtype of breast carcinoma, with 
good prognosis. They tend to present low rates of lymph node metastasis and low p53 expression, ER-positive, 
low frequency of gene copy number aberrations and high prevalence of PIK3CA mutations. The genomic pro-
file of its three morphological variants (i.e. encapsulated, solid and invasive papillary) has shown remarkably 
similar46. Likewise, mucinous breast carcinoma display ER-positivity, low level of genetic instability and rare 
recurrent amplifications48–51. These genetic features reasonably approximate both tumors in hierarchic clusters39. 
In opposition, medullary carcinomas have been shown to share the basal-like immunophenotype (i.e. HR nega-
tive, HER-2 negative and P-cadherin positive), and high frequency of chromosome aberrations39,40,52–55. In spite 
of this divergence in profiling, medullary carcinomas show, in common with the other two members of group C, 
Figure 3. Distribution of breast cancer histological subtypes per intratumoral collagen parameters. Tubular and 
invasive lobular breast carcinoma showed the highest intratumoral collagen parameters (quantity, uniformity 
and organization), while medullary, papillary and mucinous breast carcinoma presented the lowest intratumoral 
collagen parameters. Invasive ductal, metaplastic, invasive apocrine and micropapillary breast carcinomas 
presented intermediary intratumoral collagen parameters.
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the favorable prognosis and the lower intratumoral collagen quantity, uniformity and organization. As such, this 
group is homogeneous only in respect to clinical behavior for all three members45.
Metaplastic and medullary carcinomas, grouped herein as B and C, respectively, are consistently of 
triple-negative phenotype, and both were shown to display similar high frequency of gene copy number aber-
rations and comparable gene expression patterns39,40,52–55. In relation to the concordance between the molecular 
subtyping and other prognostic gene signatures, patients with the basal-like type should be classified as aggressive 
tumor9,56. However, basal-like medullary carcinomas present a good outcome in opposition to metaplastic carci-
noma3. Then, in contrast to molecular grouping, intrinsic intratumoral collagen parameters clustering proposed 
in this study assembled these subtypes of breast carcinomas more suitably.
The rarity of the entities analyzed herein represents a drawback. Additional studies of special subtypes of 
breast carcinoma will be required to validate these findings, and to determine the biological and clinical relevance 
of clustering these tumors according to the intratumoral collagen parameters. In special, studies on patients’ 
outcome for each individual subtype will require larger cohorts. Also, the long collection period might affect the 
evaluation of collagen structure, although previous studies pointed out that tissue fixation time did not interfere 
with the availability of macromolecules57,58. Further, the present study evaluated images only with the 40×/1.3 
oil immersion magnification, largely used in the literature. It would be interesting to specifically address the 
comparison of collagen parameters values between different magnifications, in order to evaluate the impact of 
microscopic resolution for these analyses.
Previous studies have already demonstrated the prognostic value of collagen parameters in breast cancer, 
showing that high disorganization of collagen fibers, i. e. TACS3, is indicative of poorer prognosis34,37. In a study 
on the evaluation of fibrils deposition in collagen fibers, it was also found that different patterns are related to the 
molecular subtypes59. However, most of them did not emphasize the usage of this technique on IBC-ST, with the 
exception of the study by Conklin et al., in which collagen parameters were evaluated in invasive lobular carci-
noma34. In addition, these studies have not compared different collagen signatures in the histological subtypes. 
Further, the method applied in the present study was quantitative, in contrast to the qualitative or semiquan-
titative approach of the previous ones. Besides, the results presented herein could provide the basis for future 
automated analyses with specific mathematical algorithms for classification, as already described60. However, this 
application is still potential, as, to the best of our knowledge, our study represents the first approach to compare 
collagen parameters in IBC-ST.
In summary, our results do not allow a prognostic stratification, but provide information that could contribute 
to refine diagnosis. In that sense, an example would be the differential diagnosis between medullary carcinomas 
and triple-negative IBC-NST, since these entities belong to different groups, as proposed here. Our results pro-
vide a step forward to the characterization of the tumor microenvironment of IBC-ST. This understanding may 
add information to build more consistent tumor categorization, together with molecular findings. Grouping the 
different histological subtypes according to collagen parameters, as suggested herein, may represent a plausible 
explanation for the observation that tumors with different genetic profiles share similar clinical behavior. It poten-
tially contributes to the refinement of the microenvironmental phylomorphology, and of the prognostication of 
breast cancer patients.
Materials and Methods
Case selection. Formalin-fixed, paraffin-embedded (FFPE) tissue specimens from 120 patients with pure 
invasive breast carcinoma were consecutively retrieved from four centers of Pathology (two in Brazil, one in 
Portugal and one in France). Tissues were obtained from primary lumpectomy or mastectomy; no patient had 
undergone primary chemo- or radiotherapy. Tumors were classified based on the WHO criteria3: 21 IBC-NST, 
7 classic invasive lobular, 13 tubular, 23 mucinous, 6 invasive micropapillary, 9 invasive papillary, 15 medullary, 
9 metaplastic and 17 apocrine carcinomas, from January 2000 to January 2015. Mucinous carcinoma were sub-
divided into hypocellular mucinous (mucinous A; n = 13) and hypercellular mucinous carcinoma (mucinous B; 
n = 10) based on the criteria of Capella et al.61. All cases were reviewed on hematoxylin and eosin-stained (H&E) 
sections by at least two experienced breast pathologists (GRP, CAA, RVF and FCS). The study is fully compliant 
with the Declaration of Helsinki (approved by the “Comitê de Ética em Pesquisa da Unicamp”).
In order to confirm diagnosis and evaluate immunohistochemical-based molecular subtype39,44, two repre-
sentative intratumoral areas of 2 mm in diameter from each case were selected to build a tissue microarray (tissue 
microarray (TMA) builder 20010.02, Histopathology, Pécs, Hungary) for the immunohistochemical analysis. 
Further, three representative regions from peri- and intratumoral areas were selected on the same H&E sections 
(4 µm each), and marked for SHG methodology (Supplementary Information 1).
Immunohistochemical staining and evaluation. TMA sections were deparaffinized, rehydrated 
and submitted to antigen retrieval. The primary antibodies used, dilutions and detection methods are briefly 
described in Supplementary Table 6. Seven cases of medullary carcinoma kindly provided by Camille Franchet 
were analyzed in whole sections. The evaluation of immunohistochemical results was centrally performed by two 
experienced breast pathologists (CAA and FCS).
Staining for estrogen-receptor alpha (ER), progesterone receptor (PR) and androgen receptor (AR) were eval-
uated according to the previously described guidelines62. For p63, keratin 5 and P-cadherin, samples were scored 
as positive when ≥10% cells were immunoreactive63. Membrane expression for HER-2 and EGFR was evaluated 
as previously described64. Ki-67 was evaluated by counting 1000 neoplastic cells in areas with highest positivity; 
cases with <20% positive cells were considered to have low proliferation, and the others, high proliferation65. 
Tumors were classified based on St Gallen Internation Expert Consensus65 (Supplementary Information 1).
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second-harmonic generation (sHG) imaging. SHG microscopy was performed on a Zeiss LSM 
780-NLO inverted confocal system (Carl Zeiss AG, Göttingen, Germany) available at the National Institute 
of Sciences and Technology on Photonics Applied to Cell Biology (INFABiC, UNICAMP) (Supplementary 
Information 1, Fig. 4 and Supplementary Fig. 7). Three peri- and three intratumoral areas selected for collagen 
assessment on H&E stained sections were examined in this condition, and digital images were collected for fur-
ther evaluation. Peritumoral regions were defined as the fibrous tissue at the tumor borders, in the transition with 
non-neoplastic tissue. Intratumoral regions corresponded to fibrous bands within groups of neoplastic cells. In 
cases with multiple tumor sections, the most representative one was chosen.
Evaluation of collagen fibers. SHG images were stratified regarding collagen parameters using image pat-
tern analysis methods. Collagen parameter refers to the pixels characterization in the SHG image, being evaluated 
through three features: quantity, uniformity and organization. Quantitative analysis of collagen parameters was 
performed in SHG images using ImageJ (http://imagej.nih.gov/ij/) and OrientationJ plug-in66. For this purpose, 
16 representative areas to cover entire image (256 × 256 pixels) were performed in each image. The final value of 
each parameter represents the average of the values obtained in the three images; the value of each image denotes 
the average of the 16 representative areas of each image. (Supplementary Information 1). IBC-NST, being the 
most common subtype of breast cancer, was used as a comparison parameter for the other cases. Therefore, spe-
cial cases may present collagen parameters equal, higher or lower than IBC-NST. Furthermore, a previous report 
demonstrated that the area of the cellular component does not represent a confounding variable in the collagen 
parameters evaluation67, so hypo- or hypercellular tumors were evaluated in the same way.
Figure 4. Autofluorescence (01, 04 and 07), fSHG collagen (02, 05 and 08) and bSHG collagen (03, 06 and 09). 
Images correspond to: invasive ductal carcinoma no special type (01, 02 and 03), classic invasive lobular (04, 05 
and 06) and tubular (07, 08 and 09). Autofluorescence was included in this Figure to show tissue architecture. 
The images were log-transformed. For more examples see Supplementary Fig. 1. [bSHG, fSHG: backward and 
forward propagation second harmonic generation, respectively].
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statistical analyses. Collagen quantity and uniformity were log-transformed to base e for statistical pur-
poses; statistical analyses were performed using R (https://cran.r-project.org/). Shapiro-Wilk test was performed 
to analyze the data distribution of collagen parameters. Comparisons were performed using t-tests or analysis of 
variance (ANOVA). Pearson’s Correlation coefficients were calculated to analyze the correlation between collagen 
parameters. A multivariate recursive partitioning model was fit to determine groups of collagen between breast 
cancer subtypes. Hierarchical clustering analysis was performed, using Euclidean distance and Ward’s cluster-
ing algorithm49,51,68 and minimal spanning tree (Supplementary Information 1). p values were corrected using 
Benjamini and Hochberg adjustment to minimize α errors, and adjusted p values less than 0.05 were considered 
significant.
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